Development
Cardinal Health, Inc.
CAH
$164.96
-$0.44-0.27%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 11.61% | 10.40% | 13.48% | 12.60% | 13.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.61% | 10.40% | 13.48% | 12.60% | 13.23% |
| Cost of Revenue | 11.63% | 10.43% | 13.47% | 12.86% | 13.61% |
| Gross Profit | 11.00% | 9.54% | 13.83% | 6.12% | 2.91% |
| SG&A Expenses | 7.72% | 0.00% | 9.70% | 3.69% | 3.48% |
| Depreciation & Amortization | -11.27% | -9.86% | -20.69% | -6.33% | -10.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.51% | 10.15% | 13.31% | 12.59% | 13.31% |
| Operating Income | 24.69% | 46.53% | 35.26% | 14.16% | 3.89% |
| Income Before Tax | 457.66% | -123.64% | 532.14% | 497.08% | 85.92% |
| Income Tax Expenses | 2,042.86% | -3,100.00% | 213.33% | -84.28% | 99.32% |
| Earnings from Continuing Operations | 372.31% | -94.59% | -148.18% | 124.96% | -365.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00% | 100.00% | -100.00% | -- |
| Net Income | 371.54% | -95.45% | -146.38% | 124.80% | -365.31% |
| EBIT | 24.69% | 46.53% | 35.26% | 14.16% | 3.89% |
| EBITDA | 18.21% | 31.33% | 23.06% | 9.27% | 3.82% |
| EPS Basic | 389.26% | -95.05% | -149.85% | 126.64% | -383.66% |
| Normalized Basic EPS | 40.86% | 69.19% | 70.98% | 27.06% | 13.10% |
| EPS Diluted | 386.00% | -95.00% | -149.94% | 126.49% | -394.12% |
| Normalized Diluted EPS | 40.29% | 69.76% | 72.23% | 26.07% | 13.90% |
| Average Basic Shares Outstanding | -6.13% | -8.12% | -6.96% | -6.91% | -6.45% |
| Average Diluted Shares Outstanding | -5.75% | -8.42% | -7.64% | -6.18% | -7.12% |
| Dividend Per Share | 0.99% | 0.99% | 2.67% | 1.00% | 1.00% |
| Payout Ratio | 1.35% | 19.30% | -3.03% | 4.79% | -1.35% |